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Gregg W. Stone, MD,* Jagat Narula, MD, PHDyM ost physicians believe that acute coronarysyndromes (ACS) are due to coronary ar-tery thrombosis resulting from plaque
rupture of a metabolically active inﬂamed lesion
characterized by a thin ﬁbrous cap (thin-cap ﬁbroa-
theroma [TCFA]), overlying a large necrotic core
containing rich concentrations of cholesterol, choles-
terol esters, and senescent macrophages (1). Such
lesions also demonstrate spotty calciﬁcation and neo-
vascularization arising from the vasa vasorum with
plaque hemorrhage. Indeed, the chemical structure
and morphology of the TCFA is so distinctive that
numerous invasive and noninvasive imaging mo-
dalities have been developed to search for the mis-
chievous TCFA prior to its becoming unstable, to
improve prognostic discrimination and perhaps guide
systemic or focal therapies.
However, although pathologic studies have dem-
onstrated that the majority of thrombotic lesions
responsible for acute myocardial infarction (AMI) and
sudden cardiac death have a ruptured ﬁbrous cap
(RFC) overlying a sizable necrotic core, the ﬁbrous
cap remains intact in a substantial minority of pla-
ques. Analyses of 22 autopsy studies of 1,847 coronary
arteries had revealed that coronary thrombosis was
associated with plaque rupture in 73% of lesions (2).
An intact ﬁbrous cap (IFC), however, was present in
27% of cases, most commonly associated with “pla-
que erosion.” Pathologically, eroded plaques are rich
in smooth muscle cells and proteoglycans, have few
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logic intimal thickening or thick-cap ﬁbroatheromas
with preservedmedia but lack a superﬁcial endothelial
layer. However, it is uncertain whether the endo-
thelial lining is disrupted before or after thrombosis.
Most (but not all) pathologic studies have reported
that lesions responsible for AMI with plaque erosion
compared with plaque rupture have less expansive
remodeling and smaller plaque burden, with less
lipid burden and less inﬂammation (1). Many studies
have also found that plaque erosions tend to occur
in younger patients, especially (pre-menopausal)
women, with cigarette smoking being the predomi-
nant risk factor (4,5). However, not all cases of AMI
with an IFC are due to plaque erosion. Other rare cau-
ses may include coronary thromboemboli (including
paradoxical emboli), vasospasm, spontaneous coro-
nary dissection, vasculitis, congenital anomalies,
trauma, severe demand ischemia, primary coagulation
disorders, and iatrogenic complications.
Plaque rupture and plaque erosion as underlying
causes of ACS have been clinically deﬁned as acute
events associated with RFC and IFC, respectively (6).
Over the past several years, several retrospective
studies have reported cases of ACS due to coronary
thrombosis associated with lesions with an IFC.
Almost all of these studies have relied on intravas-
cular imaging with optical coherence tomography
(OCT) (6–9), the only modality with sufﬁcient reso-
lution (w15 mm) capable of reliably identifying small
plaque ruptures and thrombus (although even OCT
cannot detect the absence of an endothelial lining).
Pooling 4 institutional OCT databases, Prati et al. (8)
identiﬁed 31 patients presenting with ST-segment
elevation myocardial infarction (STEMI) with coro-
nary thrombosis and an IFC. Jia et al. (9) reported that
among 126 retrospectively identiﬁed patients with
ACS who had undergone pre-intervention OCT,
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62439 (31%) had an IFC, although thrombus was absent or
the underlying plaque could not be visualized in 16 of
these cases, likely decreasing speciﬁcity (9). Unlike
plaque rupture, identifying the erosion-prone plaque
before thrombosis is, however, not currently possible
given paucity of unique features.
In this issue of iJACC, Saia et al. (10) describe the
results from the OCTAVIA (Optical Coherence To-
mography Assessment of Gender Diversity in Pri-
mary Angioplasty) trial, in which OCT was used to
prospectively characterize the underlying plaque
morphology in 97 patients with STEMI before the
implantation of drug-eluting stents. They observed
RFC to be present in approximately two-thirds of
culprit lesions, whereas thrombus with an IFC was
present in approximately one-third of lesions re-
sponsible for STEMI, with 2 additional cases due to
spontaneous coronary dissection (another possible
cause of ACS with IFC). The prospective demonstra-
tion that plaque rupture is absent in one-third of le-
sions causing STEMI, consistent with the expected
pathologic proportion attributable to plaque erosion,
is a notable achievement for which the investigators
deserve recognition. Plaques with IFC compared with
RFC presented more frequently with a patent infarct
vessel (and thus had smaller infarcts by enzymatic
estimation), reportedly had less lipidic regions ap-
parent by OCT (although OCT is unable to quantitate
plaque area and therefore cannot reliably assess
lipid burden), and had less thrombus before stenting
(and which was solely platelet-rich white thrombus,
whereas red thrombus was common to lesions with
RFC). Despite these differences, the 9-month vascular
responses to everolimus-eluting stents were similar
in lesions with IFC and RFC, with nonsigniﬁcant dif-
ferences in strut coverage, malapposition, and neo-
intimal hyperplasia.
Of great interest is whether the different
pathophysiologies underlying coronary thrombosis
with RFC versus IFC warrant different treatments.
Numerous studies have shown that the rapid per-
formance of primary percutaneous coronary inter-
vention reduces infarct size, prevents reinfarction,
and improves survival compared with ﬁbrinolytic
therapy (11). The underlying plaque morphology of
the patients enrolled in these trials is, of course,
unknown, although presumably plaque erosions
were typically represented. Plaque rupture usually
occurs in the setting of large plaque burden with
expansive remodeling, with abundant thrombus; in
such lesions, recurrent ischemia is common, and
percutaneous coronary intervention with stent im-
plantation is required for stabilization. In contrast,plaque erosions may be associated with less
thrombus burden (predominately white thrombus),
with larger lumens and preserved antegrade blood
ﬂow (5,6,12), which after thrombus aspiration may
be amenable to conservative management with
dual-antiplatelet therapy plus an antithrombin
regimen. Indeed, in the study by Prati et al. (8), 12
of 31 lesions (39%) with IFC were managed with
thrombus aspiration and dual-antiplatelet therapy
only (without balloon angioplasty or stenting), with
no clinical recurrences at median 2-year follow-up.
Although the study by Saia et al. (10) suggests a
uniform response to intervention, whether plaques
with IFC versus RFC respond differently to stents
requires further study. Even if requiring interven-
tion, STEMI lesions with an IFC may be amenable to
a deferred stenting approach, which might reduce
procedural thromboembolic complications and en-
hance myocardial salvage (13). Speaking realisti-
cally, however, routine OCT after aspiration in ACS
is unlikely to be widely adopted without a large-
scale randomized trial demonstrating improved
clinical outcomes with this strategy, which would
be difﬁcult to show given the excellent results with
contemporary drug-eluting stents. Such a strategy
might prove cost effective, however, if stenting
could be deferred in a substantial proportion of
cases (14).
It is important to acknowledge the major limita-
tions of all of the studies that have been completed to
date, including small sample sizes, selection bias,
lack of randomization, and the fact that OCT has
never been validated against the histologic diagnosis
of plaque erosion; its accuracy in this regard is un-
known. Moreover, in OCTAVIA, only 97 of 140 lesions
(69%) could even be characterized by OCT, because of
quality issues or excessive thrombus or dissection
after aspiration (10). And many questions remain as
to the safety and clinical utility of routine intravas-
cular imaging in STEMI to determine the underlying
lesion phenotype, even though it seems intuitive that
such knowledge would change therapy in some pa-
tients, hopefully for the better. Nonetheless, the
OCTAVIA investigators have stimulated us to
consider these issues and have demonstrated that
they can be studied in patients with STEMI, neces-
sary steps on the road to further improving outcomes
in ACS.
REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Jagat Narula, Mount Sinai School of Medicine, One
Gustave L. Levy Place, New York, New York 10029.
E-mail: narula@acc.org.
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 5 , 2 0 1 5 Stone and Narula
M A Y 2 0 1 5 : 6 2 3 – 5 Editor’s Page
625RE F E RENCE S1. Virmani R, Burke AP, Farb A, Kolodgie FD. Pa-
thology of the vulnerable plaque. J Am Coll Car-
diol 2006;47:C13–8.
2. Falk E, Nakano M, Bentzon JF, Finn AV,
Virmani R. Update on acute coronary syndromes:
the pathologists’ view. Eur Heart J 2013;34:719–28.
3. Virmani R, Kolodgie FD, Burke AP, Farb A,
Schwartz SM. Lessons from sudden coronary
death: a comprehensive morphological classiﬁca-
tion scheme for atherosclerotic lesions. Arte-
rioscler Thromb Vasc Biol 2000;20:1262–75.
4. Farb A, Burke AP, Tang AL, et al. Coronary
plaque erosion without rupture into a lipid core:
a frequent cause of coronary thrombosis in
sudden coronary death. Circulation 1996;93:
1354–63.
5. Burke AP, Farb A, Malcom GT, Liang Y,
Smialek J, Virmani R. Effect of risk factors on the
mechanism of acute thrombosis and sudden coro-
nary death in women. Circulation 1998;97:2110–6.6. Ozaki Y, OkumuraM, Ismail TF, et al. Coronary CT
angiographic characteristics of culprit lesions
in acute coronary syndromes not related to
plaque rupture as deﬁned by optical coherence to-
mography and angioscopy. Eur Heart J 2011;32:
2814–23.
7. Kubo T, Imanishi T, Takarada S, et al. Assess-
ment of culprit lesion morphology in acute
myocardial infarction: ability of optical coherence
tomography compared with intravascular ultra-
sound and coronary angioscopy. J Am Coll Cardiol
2007;50:933–9.
8. Prati F, Uemura S, Souteyrand G, et al. OCT-
based diagnosis and management of STEMI asso-
ciated with intact ﬁbrous cap. J Am Coll Cardiol
Img 2013;6:283–7.
9. Jia H, Abtahian F, Aguirre AD, et al. In vivo
diagnosis of plaque erosion and calciﬁed nodule in
patients with acute coronary syndrome by intra-
vascular optical coherence tomography. J Am Coll
Cardiol 2013;62:1748–58.10. Saia F, Komukai K, Capodanno D, et al. Eroded
versus ruptured plaques at the culprit site of STEMI:
in vivo pathophysiological features and response to
primary PCI. J Am Coll Cardiol Img 2015;8:566–75.
11. Stone GW. Angioplasty strategies in ST-
segment-elevation myocardial infarction: part I:
primary percutaneous coronary intervention. Cir-
culation 2008;118:538–51.
12. Kramer MC, Rittersma SZ, de Winter RJ, et al.
Relationship of thrombus healing to underlying
plaque morphology in sudden coronary death.
J Am Coll Cardiol 2010;55:122–32.
13. Carrick D, Oldroyd KG, McEntegart M, et al.
A randomized trial of deferred stenting versus im-
mediate stenting to prevent no- or slow-reﬂow in
acute ST-segment elevation myocardial infarction
(DEFER-STEMI). JAmColl Cardiol 2014;63:2088–98.
14. Braunwald E. Coronary plaque erosion:
recognition and management. J Am Coll Cardiol
Img 2013;6:288–9.
